Skin-cancer drug tested in Valley approved by FDA

A new FDA-approved drug gives hope to patients with a type of advanced skin cancer.

FDA approves new skin cancer drug

A new skin cancer drug tested for the first time in the world five years ago at the Virginia G. Piper Cancer Center at Scottsdale Healthcare just received expedited approval by the U.S. Food and Drug Administration, a remarkable accomplishment in new drug development.

Genentech receives FDA approval for Vismodegib to treat skin cancer

A new skin cancer drug tested for the first time in the world five years ago at the Virginia G. Piper Cancer Center at Scottsdale Healthcare just received expedited approval by the U.S. Food and Drug Administration, a remarkable accomplishment in new drug development.

FDA approves new skin cancer drug first tested in Arizona by Scottsdale Healthcare and TGen

( The Translational Genomics Research Institute ) A new skin cancer drug tested for the first time in the world five years ago at the Virginia G. Piper Cancer Center at Scottsdale Healthcare just received expedited approval by the US Food and Drug Administration, a remarkable accomplishment in new drug development.

Drug for Advanced Skin Cancer Wins FDA Approval

The Food and Drug Administration has for the first time approved a drug to treat advanced cases of the most common skin cancer, basal cell carcinoma, the agency announced yesterday (Jan. 30).